Skip to main content

US ClosedU.S. Closed

CCCC: C4 Therapeutics, Inc. Stock Analysis | finqOS

Healthcare · Biotechnology

C4 Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on discovering and developing innovative therapeutic candidates.

52W Range

62ndpctl

Volume

0.61×avg

Market Cap

425.68MUSD

P/E Ratio

-3.9TTM

Div Yield

-ann

Loading chart data...

Current StateState loading

C4 Therapeutics, Inc.

CCCCNASDAQ Global Select·USD·Closed

C4 Therapeutics, Inc.

CCCCNASDAQ·USD·Closed

$3.85

−6.10%

$3.85

−$0.25 (6.10%)

52W Range

62ndpctl

Volume

0.61×avg

Mkt Cap

425.68MUSD

P/E

-3.9TTM

Div Yield

–ann